Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides

A. L. Frantz, E. W. Rogier, C. R. Weber, L. Shen, D. A. Cohen, L. A. Fenton, M. E.C. Bruno, C. S. Kaetzel

Research output: Contribution to journalArticlepeer-review

191 Scopus citations

Abstract

Intestinal epithelial cells (IECs) form a physical and immunological barrier that separates the vast gut microbiota from host tissues. MyD88-dependent Toll-like receptor signaling is a key mediator of microbial-host cross-talk. We examined the role of epithelial MyD88 expression by generating mice with an IEC-targeted deletion of the Myd88 gene (MyD88 ΔIEC). Loss of epithelial MyD88 signaling resulted in increased numbers of mucus-associated bacteria; translocation of bacteria, including the opportunistic pathogen Klebsiella pneumoniae, to mesenteric lymph nodes; reduced transmucosal electrical resistance; impaired mucus-associated antimicrobial activity; and downregulated expression of polymeric immunoglobulin receptor (the epithelial IgA transporter), mucin-2 (the major protein of intestinal mucus), and the antimicrobial peptides RegIIIγ and Defa-rs1. We further observed significant differences in the composition of the gut microbiota between MyD88ΔIEC mice and wild-type littermates. These physical, immunological, and microbial defects resulted in increased susceptibility of MyD88ΔIEC mice to experimental colitis. We conclude that MyD88 signaling in IECs is crucial for maintenance of gut homeostasis.

Original languageEnglish
Pages (from-to)501-512
Number of pages12
JournalMucosal Immunology
Volume5
Issue number5
DOIs
StatePublished - Sep 2012

Funding

We thank Dr Jiayou Zhang, University of Kentucky, for supplying a bacterial plasmid encoding kanamycin resistance and green fluorescence protein, and Dr Jerrold Turner, University of Chicago, for helpful discussions. This study was supported by National Institutes of Health grant R21AI069027 (CSK) and a Crohn ’s & Colitis Foundation of America Senior Research Award (CSK).

FundersFunder number
Crohn ’s & Colitis Foundation of America
National Institutes of Health (NIH)
National Institute of Allergy and Infectious DiseasesR21AI069027

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Fingerprint

    Dive into the research topics of 'Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides'. Together they form a unique fingerprint.

    Cite this